Literature DB >> 3125050

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.

J Texier-Maugein1, M Mormède, J Fourche, C Bébéar.   

Abstract

The in vitro activity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin against 86 strains of mycobacteria was evaluated by broth dilution. While Mycobacterium avium, Mycobacterium scrofulaceum and Mycobacterium chelonae were resistant to all four antibacterials, the susceptibility of the other species, Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium xenopi and Mycobacterium fortuitum, depended on the antibiotic. Ofloxacin and ciprofloxacin (MIC90: 0.5 - 2 mg/l) were more active than pefloxacin and norfloxacin (MIC90: 2 - 16 mg/l).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125050     DOI: 10.1007/bf02014255

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  6 in total

1.  In-vitro susceptibility of mycobacteria to ciprofloxacin.

Authors:  C H Collins; A H Uttley
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

2.  [Salvage treatment of multi-resistant pulmonary tuberculosis. Efficacy of pefloxacine].

Authors:  A Fur; F Massin; P Camus; A Waldner; L Jeannin
Journal:  Presse Med       Date:  1987-01-31       Impact factor: 1.228

3.  In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.

Authors:  M Tsukamura
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

4.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors:  J D Gay; D R DeYoung; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

5.  Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

Authors:  M Tsukamura; E Nakamura; S Yoshii; H Amano
Journal:  Am Rev Respir Dis       Date:  1985-03

6.  Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Authors:  C H Fenlon; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

  6 in total
  9 in total

1.  Resistance status of Mycobacterium tuberculosis on the island of Crete, Greece.

Authors:  I K Neonakis; Z Gitti; M Baritaki; I S Kourbeti; S Baritaki; E Petinaki; S Maraki; E Krambovitis; D A Spandidos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

Review 2.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.

Authors:  Michael D Adjei; Thomas M Heinze; Joanna Deck; James P Freeman; Anna J Williams; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 6.  Newly documented antimicrobial activity of quinolones.

Authors:  Y X Furet; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 7.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

8.  Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.

Authors:  N Mor; J Vanderkolk; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

9.  Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.

Authors:  S Y Tsui; W W Yew; M S Li; C Y Chan; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.